These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3908004)
1. Clinical pharmacokinetics of methotrexate in psoriasis therapy. Hendel J Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004 [No Abstract] [Full Text] [Related]
2. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis. Furst DE J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():11-4. PubMed ID: 3913770 [TBL] [Abstract][Full Text] [Related]
4. [Methotrexate treatment of psoriasis]. Tessmann K Dermatol Monatsschr; 1969; 155(9):719-23. PubMed ID: 5397170 [No Abstract] [Full Text] [Related]
5. [Correct use of methotrexate]. Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A Ned Tijdschr Geneeskd; 2009; 153():A696. PubMed ID: 19785852 [TBL] [Abstract][Full Text] [Related]
6. The pharmacology and clinical use of methotrexate. Jolivet J; Cowan KH; Curt GA; Clendeninn NJ; Chabner BA N Engl J Med; 1983 Nov; 309(18):1094-104. PubMed ID: 6353235 [No Abstract] [Full Text] [Related]
7. Folate supplementation during methotrexate therapy for patients with psoriasis. Strober BE; Menon K J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787 [TBL] [Abstract][Full Text] [Related]
8. Methotrexate for psoriasis: current European practice. A postal survey. Boffa MJ J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290 [TBL] [Abstract][Full Text] [Related]
9. Tissue distribution of folate antagonists. Oliverio VT; Zaharko DS Ann N Y Acad Sci; 1971 Nov; 186():387-99. PubMed ID: 4943809 [No Abstract] [Full Text] [Related]
10. Folic acid supplementation and methotrexate therapy for psoriasis. Hughes R; Harries M; Chalmers RJ; Kirby B J Am Acad Dermatol; 2006 Aug; 55(2):366-7. PubMed ID: 16844540 [No Abstract] [Full Text] [Related]
13. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells. Sirotnak FM; Donsbach RC Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750 [No Abstract] [Full Text] [Related]
14. Urinary and biliary excretion of the 2,4-diaminoquinazoline antifolate, methasquin, in rats and dogs. Rader JI; Hutchison DJ; Sodergren JE; Vidal P; Philips FS Cancer Res; 1971 Jul; 31(7):964-9. PubMed ID: 4997848 [No Abstract] [Full Text] [Related]
15. The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis. Warren RB; Griffiths CE Br J Dermatol; 2005 Nov; 153(5):869-73. PubMed ID: 16225593 [TBL] [Abstract][Full Text] [Related]
16. Transport of folates and antifolates in liver. Horne DW Proc Soc Exp Biol Med; 1993 Apr; 202(4):385-91. PubMed ID: 8456101 [TBL] [Abstract][Full Text] [Related]
17. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic. Barker J; Horn EJ; Lebwohl M; Warren RB; Nast A; Rosenberg W; Smith C; J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):758-64. PubMed ID: 21198946 [TBL] [Abstract][Full Text] [Related]